Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why
PM360
AUGUST 9, 2022
According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. Pharma companies have shifted their focus to specialized conditions such as multiple sclerosis and ulcerative colitis. By 2020, that percentage plummeted to just 8%. Symphony Health Solutions, practitioner insight’s data, 2022.
Let's personalize your content